Fort Washington Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.6M Buy
2,061,791
+19,752
+1% +$517K 0.25% 106
2026
Q1
$57.3M Buy
2,042,039
+103,010
+5% +$2.74M 0.32% 80
2025
Q4
$48.3M Buy
1,939,029
+46,366
+2% +$1.17M 0.26% 97
2025
Q3
$48.2M Buy
1,892,663
+190,946
+11% +$4.71M 0.26% 95
2025
Q2
$41.2M Buy
1,701,717
+18,896
+1% +$441K 0.24% 102
2025
Q1
$42.6M Buy
1,682,821
+53,433
+3% +$1.4M 0.26% 97
2024
Q4
$43.2M Buy
1,629,388
+22,562
+1% +$612K 0.26% 97
2024
Q3
$46.5M Buy
1,606,826
+6,947
+0.4% +$203K 0.28% 90
2024
Q2
$44.8M Sell
1,599,879
-117,347
-7% -$3.23M 0.29% 85
2024
Q1
$47.7M Buy
1,717,226
+5,044
+0.3% +$140K 0.31% 84
2023
Q4
$49.3M Buy
1,712,182
+21,857
+1% +$661K 0.34% 77
2023
Q3
$56.1M Buy
1,690,325
+651,554
+63% +$23M 0.42% 64
2023
Q2
$38.1M Buy
1,038,771
+234,392
+29% +$9.12M 0.28% 90
2023
Q1
$32.8M Sell
804,379
-94,066
-10% -$4.06M 0.25% 105
2022
Q4
$46M Buy
898,445
+3,208
+0.4% +$154K 0.36% 83
2022
Q3
$39.2M Hold
895,237
0.33% 90
2022
Q2
$46.9M Buy
895,237
+13,783
+2% +$702K 0.36% 82
2022
Q1
$45.6M Sell
881,454
-133,094
-13% -$6.91M 0.29% 95
2021
Q4
$59.9M Sell
1,014,548
-552,495
-35% -$27.4M 0.36% 74
2021
Q3
$67.4M Buy
1,567,043
+1,209,081
+338% +$53.6M 0.43% 63
2021
Q2
$14M Buy
357,962
+650
+0.2% +$25.3K 0.12% 116
2021
Q1
$12.9M Buy
357,312
+5,777
+2% +$205K 0.12% 118
2020
Q4
$12.9M Sell
351,535
-5,501
-2% -$202K 0.14% 106
2020
Q3
$12.4M Buy
357,036
+8,020
+2% +$281K 0.13% 104
2020
Q2
$10.8M Hold
349,016
0.12% 120
2020
Q1
$10.8M Sell
349,016
-47,570
-12% -$1.62M 0.15% 119
2019
Q4
$14.7M Buy
396,586
+97,562
+33% +$3.48M 0.16% 115
2019
Q3
$10.2M Buy
299,024
+97,168
+48% +$3.53M 0.11% 177
2019
Q2
$8.3M Buy
201,856
+322
+0.2% +$12.8K 0.09% 177
2019
Q1
$8.12M Sell
201,534
-17,971
-8% -$720K 0.09% 173
2018
Q4
$9.09M Sell
219,505
-84,920
-28% -$3.53M 0.11% 162
2018
Q3
$12.7M Sell
304,425
-890
-0.3% -$34.3K 0.13% 172
2018
Q2
$10.5M Buy
305,315
+587
+0.2% +$20.1K 0.11% 188
2018
Q1
$10.3M Sell
304,728
-53,821
-15% -$1.85M 0.11% 190
2017
Q4
$12.3M Sell
358,549
-2,305
-0.6% -$78.6K 0.12% 197
2017
Q3
$12.2M Sell
360,854
-13,581
-4% -$436K 0.19% 83
2017
Q2
$11.9M Buy
374,435
+968
+0.3% +$30.5K 0.19% 79
2017
Q1
$12.1M Buy
373,467
+644
+0.2% +$20.3K 0.19% 79
2016
Q4
$11.5M Sell
372,823
-1,207
-0.3% -$36.8K 0.19% 77
2016
Q3
$12M Buy
374,030
+125,523
+51% +$4.2M 0.22% 78
2016
Q2
$8.3M Sell
248,507
-13,590
-5% -$434K 0.16% 97
2016
Q1
$7.37M Buy
262,097
+1,583
+0.6% +$45.2K 0.14% 104
2015
Q4
$7.98M Sell
260,514
-1,504
-0.6% -$47.3K 0.16% 99
2015
Q3
$7.81M Sell
262,018
-81,728
-24% -$2.62M 0.16% 101
2015
Q2
$10.9M Buy
343,746
+3,501
+1% +$114K 0.2% 90
2015
Q1
$11.2M Buy
340,245
+6,728
+2% +$214K 0.22% 92
2014
Q4
$9.86M Buy
333,517
+27,701
+9% +$794K 0.2% 99
2014
Q3
$8.58M Sell
305,816
-1,156
-0.4% -$32.4K 0.18% 108
2014
Q2
$8.64M Buy
306,972
+238,582
+349% +$6.8M 0.17% 126
2014
Q1
$2.08M Sell
68,390
-1,274
-2% -$38K 0.04% 209
2013
Q4
$2.02M Sell
69,664
-4,150
-6% -$121K 0.05% 262
2013
Q3
$2.01M Sell
73,814
-5,610
-7% -$153K 0.05% 266
2013
Q2
$2.11M Buy
+79,424
New +$2.19M 0.05% 262

Other funds holding PFE

Fort Washington Investment Advisors's PFE Position: Q2 2026 in Review

Fort Washington Investment Advisors increased its Pfizer (PFE) stake by 0.97% in Q2 2026, buying an estimated $517K and bringing the position to 2,061,791 shares worth $49.6M. The position accounts for 0.25% of the portfolio, ranked #106.

Fort Washington Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $67.4M in Q3 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fort Washington Investment Advisors held 2,061,791 shares of Pfizer worth $49.6M as of Q2 2026.
  • Fort Washington Investment Advisors bought 19,752 Pfizer shares in Q2 2026, an estimated $517K.
  • Pfizer made up 0.25% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #106 holding.
  • Fort Washington Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Fort Washington Investment Advisors's Pfizer position peaked at $67.4M in Q3 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.